Search Results - "Bosch‐Barrera, Joaquim"
-
1
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype
Published in Oncotarget (20-05-2015)“…Metabolic flexibility might be particularly constrained in tumors bearing mutations in isocitrate dehydrogenase 1 (IDH1) leading to the production of the…”
Get full text
Journal Article -
2
LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology
Published in Cancer medicine (Malden, MA) (01-09-2021)“…Objectives The aim of LungBEAM was to determine the value of a novel epidermal growth factor receptor (EGFR) mutation test in blood based on BEAMing technology…”
Get full text
Journal Article -
3
STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis
Published in Nature medicine (01-07-2018)“…The brain microenvironment imposes a particularly intense selective pressure on metastasis-initiating cells, but successful metastases bypass this control…”
Get full text
Journal Article -
4
Metformin: multi-faceted protection against cancer
Published in Oncotarget (01-12-2011)“…The biguanide metformin, a widely used drug for the treatment of type 2 diabetes, may exert cancer chemopreventive effects by suppressing the transformative…”
Get full text
Journal Article -
5
Metformin Is a Direct SIRT1-Activating Compound: Computational Modeling and Experimental Validation
Published in Frontiers in endocrinology (Lausanne) (06-11-2018)“…Metformin has been proposed to operate as an agonist of SIRT1, a nicotinamide adenine dinucleotide (NAD )-dependent deacetylase that mimics most of the…”
Get full text
Journal Article -
6
Silibinin Suppresses the Hyperlipidemic Effects of the ALK-Tyrosine Kinase Inhibitor Lorlatinib in Hepatic Cells
Published in International journal of molecular sciences (01-09-2022)“…The third-generation anaplastic lymphoma tyrosine kinase inhibitor (ALK-TKI) lorlatinib has a unique side effect profile that includes hypercholesteremia and…”
Get full text
Journal Article -
7
AZ12756122, a novel fatty acid synthase inhibitor, decreases resistance features in EGFR-TKI resistant EGFR-mutated NSCLC cell models
Published in Biomedicine & pharmacotherapy (01-12-2022)“…Different EGFR tyrosine kinase inhibitors (TKIs) have been developed for the treatment of non-small cell lung cancer (NSCLC) patients harboring sensitizing…”
Get full text
Journal Article -
8
Intestinal Permeability Study of Clinically Relevant Formulations of Silibinin in Caco-2 Cell Monolayers
Published in International journal of molecular sciences (31-03-2019)“…An ever-growing number of preclinical studies have investigated the tumoricidal activity of the milk thistle flavonolignan silibinin. The clinical value of…”
Get full text
Journal Article -
9
Epidemiology, treatment, and survival in small cell lung cancer in Spain: Data from the Thoracic Tumor Registry
Published in PloS one (02-06-2021)“…Background Small-cell lung cancer (SCLC) is an aggressive disease with high metastatic potential and poor prognosis. Due to its low prevalence, epidemiological…”
Get full text
Journal Article -
10
Lung Cancer Management with Silibinin: A Historical and Translational Perspective
Published in Pharmaceuticals (Basel, Switzerland) (11-06-2021)“…The flavonolignan silibinin, the major bioactive component of the silymarin extract of Silybum marianum (milk thistle) seeds, is gaining traction as a novel…”
Get full text
Journal Article -
11
The role of multimorbidity in short-term mortality of lung cancer patients in Spain: a population-based cohort study
Published in BMC cancer (24-09-2021)“…Chronic diseases often occur simultaneously and tend to be associated with adverse health outcomes, but limited research has been undertaken to understand…”
Get full text
Journal Article -
12
ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer
Published in BMC cancer (22-07-2024)“…Carboplatin and paclitaxel (CP) have been the standard of care for advanced/recurrent endometrial cancer (EC) for many years. However, this chemotherapy…”
Get full text
Journal Article -
13
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
Published in Oncotarget (01-04-2012)“…Trastuzumab-refractory breast cancer stem cells (CSCs) could also explain the high rate of primary resistance to single-agent trastuzumab in HER2…”
Get full text
Journal Article -
14
-
15
Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin
Published in Oncotarget (31-05-2016)“…Despite multimodal treatment approaches, the prognosis of brain metastases (BM) from non-small cell lung cancer (NSCLC) remains poor. Untreated patients with…”
Get full text
Journal Article -
16
IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations
Published in Scientific reports (02-09-2013)“…Using non-small cell lung carcinoma (NSCLC) cells harboring the erlotinib-sensitizing Epidermal Growth Factor Receptor ( EGFR ) exon 19 mutation delE746-A750 ,…”
Get full text
Journal Article -
17
Extra Virgin Olive Oil Contains a Phenolic Inhibitor of the Histone Demethylase LSD1/KDM1A
Published in Nutrients (19-07-2019)“…The lysine-specific histone demethylase 1A (LSD1) also known as lysine (K)-specific demethylase 1A (KDM1A) is a central epigenetic regulator of metabolic…”
Get full text
Journal Article -
18
Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin
Published in Pharmaceuticals (Basel, Switzerland) (24-12-2021)“…COVID-19 pathophysiology is caused by a cascade of respiratory and multiorgan failures arising, at least in part, from the SARS-CoV-2-driven dysregulation of…”
Get full text
Journal Article -
19
Abstract 2746: Stat3 labels a subpopulation of reactive astrocytes required for brain metastasis
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…The diagnosis of brain metastasis involves high morbidity and mortality and remains as an unmet clinical need in spite of being the most common tumor in the…”
Get full text
Journal Article -
20
Metformin lowers the threshold for stress-induced senescence: A role for the microRNA-200 family and miR-205
Published in Cell cycle (Georgetown, Tex.) (15-03-2012)“…We have tested the hypothesis that the antidiabetic biguanide metformin can be used to manipulate the threshold for stress-induced senescence (SIS), thus…”
Get full text
Journal Article